Amsterdam UMC - AMC, Department of Laboratory Medicine, Laboratory Genetic Metabolic Diseases, Amsterdam, The Netherlands; Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam, The Netherlands; Amsterdam Reproduction & Development, Amsterdam, The Netherlands; United for Metabolic Diseases, The Netherlands.
Amsterdam UMC - AMC, Department of Laboratory Medicine, Laboratory Genetic Metabolic Diseases, Amsterdam, The Netherlands.
Genet Med. 2023 Nov;25(11):100944. doi: 10.1016/j.gim.2023.100944. Epub 2023 Jul 23.
Zellweger spectrum disorders (ZSDs) are known as autosomal recessive disorders caused by defective peroxisome biogenesis due to bi-allelic pathogenic variants in any of at least 13 different PEX genes. Here, we report 2 unrelated patients who present with an autosomal dominant ZSD.
We performed biochemical and genetic studies in blood and skin fibroblasts of the patients and demonstrated the pathogenicity of the identified PEX14 variants by functional cell studies.
We identified 2 different single heterozygous de novo variants in the PEX14 genes of 2 patients diagnosed with ZSD. Both variants cause messenger RNA mis-splicing, leading to stable expression of similar C-terminally truncated PEX14 proteins. Functional studies indicated that the truncated PEX14 proteins lost their function in peroxisomal matrix protein import and cause increased degradation of peroxisomes, ie, pexophagy, thus exerting a dominant-negative effect on peroxisome functioning. Inhibition of pexophagy by different autophagy inhibitors or genetic knockdown of the peroxisomal autophagy receptor NBR1 resulted in restoration of peroxisomal functions in the patients' fibroblasts.
Our finding of an autosomal dominant ZSD expands the genetic repertoire of ZSDs. Our study underscores that single heterozygous variants should not be ignored as possible genetic cause of diseases with an established autosomal recessive mode of inheritance.
Zellweger 谱系障碍(ZSD)是一种常染色体隐性疾病,由于至少 13 种不同 PEX 基因中的双等位基因致病性变异导致过氧化物酶体生物发生缺陷而引起。在这里,我们报告了 2 例具有常染色体显性遗传的 ZSD 无关患者。
我们对患者的血液和皮肤成纤维细胞进行了生化和遗传学研究,并通过功能细胞研究证明了鉴定出的 PEX14 变异的致病性。
我们在 2 名被诊断为 ZSD 的患者的 PEX14 基因中发现了 2 个不同的单杂合新生变异。这两种变异均导致信使 RNA 剪接错误,导致相似的 C 末端截断 PEX14 蛋白的稳定表达。功能研究表明,截短的 PEX14 蛋白丧失了其在过氧化物酶体基质蛋白导入中的功能,并导致过氧化物酶体的降解增加,即 pexophagy,从而对过氧化物酶体的功能产生显性负效应。用不同的自噬抑制剂抑制 pexophagy 或遗传敲低过氧化物酶体自噬受体 NBR1,可恢复患者成纤维细胞中的过氧化物酶体功能。
我们发现的常染色体显性 ZSD 扩大了 ZSD 的遗传谱。我们的研究强调,单杂合变异不应被忽视,因为它可能是具有已建立的常染色体隐性遗传模式的疾病的遗传原因。